Regulations/Legal

Latest Issue of OR Manager
February 2025
Home Regulations/Legal

The Joint Commission releases sentinel event data for CY 2022

Editor's Note The Joint Commission, on April 4, released its Sentinel Event Data 2022 Annual Review, which covered serious adverse events from January 1 through December 31, 2022. There were 1,441 sentinel events reported in 2022, a 19% increase over 2021, and a 78% increase over 2020, with COVID-19 continuing…

Read More

By: Judy Mathias
April 4, 2023
Share

New Omicron subvariant emerging

Editor's Note The World Health Organization on March 30 reported that although there is an overall downward trend in COVID-19 cases and deaths, 21 countries are reporting increases in cases of Omicron subvariant XBB.1.16, particularly India. XBB.1.16 has a similar profile to XBB.1.5, which is the dominant strain in the…

Read More

By: Judy Mathias
April 3, 2023
Share

Missouri latest state to introduce legislation to curb travel nursing rates

Editor's Note The state of Missouri is the most recent state—out of 11—to propose legislation and/or regulations to curb or cap “price gouging” on travel nursing from healthcare staffing agencies, USA Today March 16 reports. The proposed legislation out of Missouri would reportedly allow for felony charges to be brought…

Read More

By: Tarsilla Moura
March 31, 2023
Share

Cluster of mycobacteria infections after total joints traced to OR nurse

Editor's Note This investigation by the Kentucky Department for Public Health and Centers for Disease Control and Prevention of eight cases of rapidly growing mycobacteria (RGM) infections in a Kentucky hospital after total joint replacement procedures found that the presence of a particular OR nurse was significantly associated with the…

Read More

By: Judy Mathias
March 30, 2023
Share

Sponsored Message

ASA urges public to learn to recognize opioid overdose and how to use naloxone

Editor's Note The American Society of Anesthesiologists (ASA), on March 29, issued a news report urging the public to learn to recognize and respond to an opioid overdose, now that the Food and Drug Administration has approved naloxone for sale over the counter. Naloxone, which is commonly sold as a…

Read More

By: Judy Mathias
March 30, 2023
Share

Telehealth care, MOUD during COVID-19 reduced risk for fatal drug overdoses

Editor's Note This study led by researchers from the Centers for Medicare and Medicaid Services and Centers for Disease Control and Prevention finds that federal actions taken to expand telehealth use for Medicare patients with opioid use disorder (OUD) and to facilitate provision of medications for OUD (MOUD) were associated…

Read More

By: Judy Mathias
March 30, 2023
Share

Sponsored Message

CDC: One bivalent COVID-19 booster is sufficient for now

Editor's Note The Centers for Disease Control and Prevention (CDC), on March 29, updated its COVID-19 vaccination guidelines to say that one dose of the bivalent booster is all that is recommended at this time, even for those who were last vaccinated more than 6 months ago. The CDC notes…

Read More

By: Judy Mathias
March 30, 2023
Share

WHO updates COVID-19 vaccination guidance

Editor's Note The World Health Organization, on March 28, announced the revision of it’s guidance for prioritizing the use of COVID-19 vaccines after the meeting of its Strategic Advisory Group of Experts on Immunization (SAGE). The guidance was revised to reflect that much of the population has either been vaccinated…

Read More

By: Judy Mathias
March 29, 2023
Share

Candida auris fungas on the rise

Editor's Note The Centers for Diseas Control and Prevention issued an alert that infections from the fungus Candida auris are increasing, according to a March 23 report from Michigan Medicine. Highlights from the report include: Patients in nursing facilities who have ventilator-associated infections are at increased risk, and ventilators have…

Read More

By: Judy Mathias
March 28, 2023
Share

Impact of expectations, prior experiences on adverse effect reports after COVID-19 vaccinations

Editor's Note This German study finds that expectations and prior experiences were associated with increased adverse effect reports in individuals receiving their second COVID-19 vaccinations. Researchers collected data from 1,678 individuals receiving Pfizer BioNTech and Moderna mRNA vaccines. Severe adverse effect reports were higher in those: expecting a lower benefit…

Read More

By: Judy Mathias
March 27, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat